Stay updated with breaking news from Lars Edvinsson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Karolinska Institutet have identified an interesting potential future therapeutic target in primary headache disorders. They have found increased amounts of a gene associated with cluster headache, MERTK, and its ligand Gal-3, in tissue from cluster headache patients. Their study is published in the Journal of Headache and Pain.
Restarting a CGRP monoclonal antibody (mAb) after a gap in treatment may lower response rate, a new study suggests. However, switching to a different mAb may counter this effect.
Patients with migraine are less likely to respond to the new CGRP monoclonal antibody preventive treatments, if they have certain psychiatric disorders, new research shows.
Dr Peter Goadsby’s pioneering work has changed our understanding of migraines. Eva Wiseman, who has endured them since she was a child, hears how he found his way to the source of the pain – and what can be done about it
Scientists win prize for migraine research that offers 'light at the end of the tunnel' Neuroscientist Peter Goadsby wants the millions of people who suffer from migraines to know that there is a "light at the end of the tunnel." And now his treatment for the long misunderstood disease has been recognized by the world's largest neuroscience prize. Social Sharing CBC Radio · Posted: Mar 11, 2021 5:52 PM ET | Last Updated: March 11 Award-winning migraine research could help people regain control over their lives, say the scientists responsible. (Media for Medical/UIG/Getty)